Average Co-Inventor Count = 4.83
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (20 from 3,681 patents)
2. Domantis Limited (12 from 38 patents)
3. Bristol Meyers Squibb Company (1 from 41 patents)
21 patents:
1. 12012452 - Compositions monovalent for CD28 binding and methods of use
2. 11912769 - Methods of treating systemic lupus erythematosus using a domain antibody directed against CD28
3. 11267888 - Methods of treating systemic lupus erythematosus using a domain antibody directed against CD28
4. 11180567 - Antibody polypeptides that antagonize CD40L
5. 10919965 - Compositions monovalent for CD28 binding and methods of use
6. 10196451 - Methods of treating immune diseases by administering antibody polypeptides that specifically bind CD40L
7. 9908937 - Compositions monovalent for CD28 binding and methods of use
8. 9765150 - Antibody polypeptides that antagonize CD40L
9. 9228018 - Antibody polypeptides that antagonize CD40L
10. 9085629 - Compositions monovalent for CD28 binding and methods of use
11. 8981072 - Nucleic acids encoding antibody polypeptides that antagonize CD40L
12. 8895010 - Antibody polypeptides that antagonize CD40L
13. 8454959 - Compositions monovalent for CD28 binding and methods of use
14. 8168759 - Compositions monovalent for CD28 binding and methods of use
15. 7670785 - Polynucleotides and polypeptides associated with the development of rheumatoid arthritis